A randomized split-face, investigator-blinded study of a picosecond Alexandrite laser for post-inflammatory erythema and acne scars

Xiang Wen, Yong Li, Michael R. Hamblin, Xian Jiang

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

The 755 nm picosecond Alexandrite laser has been demonstrated to be effective and well tolerated in patients with acne scars. In this split-face, investigator-blinded study, 16 patients with post-inflammatory erythema (PIE) and acne scars were randomized to receive laser treatment on half the face, with the other half serving as a control. The treatment side demonstrated a significant improvement in both PIE and scars compared to the baseline and also when compared to the control side. Treatment was well-tolerated, with only transient and mild erythema and edema reported as side-effects. In our study, the picosecond Alexandrite laser was safe and effective in the treatment of PIE and acne scars. Comprehensive treatment outcomes should be taken into consideration when deciding on which device to use.

Original languageEnglish
Article numbere13941
JournalDermatologic Therapy
Volume33
Issue number6
DOIs
Publication statusPublished - 1 Nov 2020

Keywords

  • acne scars
  • picosecond alexandrite laser
  • post-inflammatory erythema
  • randomized
  • split-face

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'A randomized split-face, investigator-blinded study of a picosecond Alexandrite laser for post-inflammatory erythema and acne scars'. Together they form a unique fingerprint.

Cite this